+
データを開く
-
基本情報
| 登録情報 | データベース: PDB / ID: 3b7o | ||||||
|---|---|---|---|---|---|---|---|
| タイトル | Crystal structure of the human tyrosine phosphatase SHP2 (PTPN11) with an accessible active site | ||||||
要素 | Tyrosine-protein phosphatase non-receptor type 11 | ||||||
キーワード | HYDROLASE / SHP2 / PTPN11 / tyrosine phosphatase / Structural Genomics / Structural Genomics Consortium / SGC / Deafness / Disease mutation / Phosphorylation / Protein phosphatase / SH2 domain | ||||||
| 機能・相同性 | 機能・相同性情報negative regulation of cortisol secretion / intestinal epithelial cell migration / microvillus organization / negative regulation of growth hormone secretion / genitalia development / atrioventricular canal development / negative regulation of cell adhesion mediated by integrin / STAT5 Activation / Co-inhibition by BTLA / Netrin mediated repulsion signals ...negative regulation of cortisol secretion / intestinal epithelial cell migration / microvillus organization / negative regulation of growth hormone secretion / genitalia development / atrioventricular canal development / negative regulation of cell adhesion mediated by integrin / STAT5 Activation / Co-inhibition by BTLA / Netrin mediated repulsion signals / negative regulation of neutrophil activation / cerebellar cortex formation / positive regulation of hormone secretion / regulation of protein export from nucleus / Interleukin-37 signaling / positive regulation of lipopolysaccharide-mediated signaling pathway / positive regulation of ossification / Signaling by Leptin / MET activates PTPN11 / hormone metabolic process / Regulation of RUNX1 Expression and Activity / negative regulation of chondrocyte differentiation / Signal regulatory protein family interactions / face morphogenesis / ERBB signaling pathway / platelet formation / triglyceride metabolic process / organ growth / megakaryocyte development / Interleukin-20 family signaling / negative regulation of type I interferon production / Interleukin-6 signaling / PI-3K cascade:FGFR3 / Co-inhibition by CTLA4 / Platelet sensitization by LDL / STAT5 activation downstream of FLT3 ITD mutants / PI-3K cascade:FGFR2 / peptide hormone receptor binding / PI-3K cascade:FGFR4 / PI-3K cascade:FGFR1 / MAPK3 (ERK1) activation / Prolactin receptor signaling / neurotrophin TRK receptor signaling pathway / regulation of cell adhesion mediated by integrin / regulation of type I interferon-mediated signaling pathway / MAPK1 (ERK2) activation / platelet-derived growth factor receptor signaling pathway / PECAM1 interactions / Bergmann glial cell differentiation / inner ear development / peptidyl-tyrosine dephosphorylation / non-membrane spanning protein tyrosine phosphatase activity / phosphoprotein phosphatase activity / positive regulation of intracellular signal transduction / Regulation of IFNA/IFNB signaling / RET signaling / Interleukin-3, Interleukin-5 and GM-CSF signaling / PI3K Cascade / Co-inhibition by PD-1 / fibroblast growth factor receptor signaling pathway / GAB1 signalosome / positive regulation of insulin receptor signaling pathway / ephrin receptor signaling pathway / regulation of protein-containing complex assembly / Regulation of IFNG signaling / Activated NTRK2 signals through FRS2 and FRS3 / GPVI-mediated activation cascade / FRS-mediated FGFR3 signaling / Signaling by CSF3 (G-CSF) / cell adhesion molecule binding / negative regulation of T cell proliferation / T cell costimulation / Signaling by FLT3 ITD and TKD mutants / FRS-mediated FGFR2 signaling / FRS-mediated FGFR4 signaling / hormone-mediated signaling pathway / FRS-mediated FGFR1 signaling / Tie2 Signaling / phosphotyrosine residue binding / protein-tyrosine-phosphatase / FLT3 Signaling / Downstream signal transduction / homeostasis of number of cells within a tissue / positive regulation of mitotic cell cycle / axonogenesis / protein tyrosine phosphatase activity / positive regulation of interferon-beta production / protein tyrosine kinase binding / cellular response to epidermal growth factor stimulus / DNA damage checkpoint signaling / Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) / integrin-mediated signaling pathway / positive regulation of D-glucose import across plasma membrane / insulin receptor binding / Negative regulation of FGFR3 signaling / Negative regulation of FGFR2 signaling / Negative regulation of FGFR4 signaling / Negative regulation of FGFR1 signaling / cellular response to mechanical stimulus / Spry regulation of FGF signaling 類似検索 - 分子機能 | ||||||
| 生物種 | Homo sapiens (ヒト) | ||||||
| 手法 | X線回折 / シンクロトロン / 分子置換 / 解像度: 1.6 Å | ||||||
データ登録者 | Ugochukwu, E. / Barr, A. / Patel, A. / King, O. / Niesen, F. / Salah, E. / Savitsky, P. / Pilka, E.S. / Elkins, J. / Arrowsmith, C.H. ...Ugochukwu, E. / Barr, A. / Patel, A. / King, O. / Niesen, F. / Salah, E. / Savitsky, P. / Pilka, E.S. / Elkins, J. / Arrowsmith, C.H. / Weigelt, J. / Edwards, A.M. / von Delft, F. / Knapp, S. / Structural Genomics Consortium (SGC) | ||||||
引用 | ジャーナル: Cell(Cambridge,Mass.) / 年: 2009タイトル: Large-scale structural analysis of the classical human protein tyrosine phosphatome. 著者: Barr, A.J. / Ugochukwu, E. / Lee, W.H. / King, O.N. / Filippakopoulos, P. / Alfano, I. / Savitsky, P. / Burgess-Brown, N.A. / Muller, S. / Knapp, S. | ||||||
| 履歴 |
|
-
構造の表示
| 構造ビューア | 分子: Molmil Jmol/JSmol |
|---|
-
ダウンロードとリンク
-
ダウンロード
| PDBx/mmCIF形式 | 3b7o.cif.gz | 76.7 KB | 表示 | PDBx/mmCIF形式 |
|---|---|---|---|---|
| PDB形式 | pdb3b7o.ent.gz | 55.6 KB | 表示 | PDB形式 |
| PDBx/mmJSON形式 | 3b7o.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
| その他 | その他のダウンロード |
-検証レポート
| 文書・要旨 | 3b7o_validation.pdf.gz | 445.4 KB | 表示 | wwPDB検証レポート |
|---|---|---|---|---|
| 文書・詳細版 | 3b7o_full_validation.pdf.gz | 446.3 KB | 表示 | |
| XML形式データ | 3b7o_validation.xml.gz | 14.7 KB | 表示 | |
| CIF形式データ | 3b7o_validation.cif.gz | 21.7 KB | 表示 | |
| アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/b7/3b7o ftp://data.pdbj.org/pub/pdb/validation_reports/b7/3b7o | HTTPS FTP |
-関連構造データ
| 関連構造データ | ![]() 2ahsC ![]() 2b49C ![]() 2cfvC ![]() 2cjzC ![]() 2gjtC ![]() 2h4vC ![]() 2i75C ![]() 2jjdC ![]() 2nlkC ![]() 2nz6C ![]() 2oc3C ![]() 2ooqC ![]() 2p6xC ![]() 2pa5C ![]() 2qepC ![]() 2shpS S: 精密化の開始モデル C: 同じ文献を引用 ( |
|---|---|
| 類似構造データ |
-
リンク
-
集合体
| 登録構造単位 | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||
| 単位格子 |
|
-
要素
| #1: タンパク質 | 分子量: 36879.723 Da / 分子数: 1 / 断片: 'Residues 237-529 (Isoform 2)' / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: PTPN11, PTP2C, SHPTP2 / プラスミド: pNIC28-Bsa4 / 発現宿主: ![]() |
|---|---|
| #2: 化合物 | ChemComp-MLT / |
| #3: 水 | ChemComp-HOH / |
-実験情報
-実験
| 実験 | 手法: X線回折 / 使用した結晶の数: 1 |
|---|
-
試料調製
| 結晶 | マシュー密度: 2.19 Å3/Da / 溶媒含有率: 43.79 % |
|---|---|
| 結晶化 | 温度: 293 K / 手法: 蒸気拡散法, シッティングドロップ法 / pH: 7.5 詳細: 20% PEG 3350, 0.15 M Na Malate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K |
-データ収集
| 回折 | 平均測定温度: 100 K |
|---|---|
| 放射光源 | 由来: シンクロトロン / サイト: SLS / ビームライン: X10SA / 波長: 1.00721 Å |
| 検出器 | タイプ: MARMOSAIC 225 mm CCD / 検出器: CCD / 日付: 2007年7月15日 |
| 放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
| 放射波長 | 波長: 1.00721 Å / 相対比: 1 |
| 反射 | 解像度: 1.6→34.12 Å / Num. all: 43184 / Num. obs: 43184 / % possible obs: 99.9 % / Observed criterion σ(F): 0 / Observed criterion σ(I): 0 / 冗長度: 4.1 % / Biso Wilson estimate: 19.1 Å2 / Rmerge(I) obs: 0.092 / Rsym value: 0.092 / Net I/σ(I): 13.3 |
| 反射 シェル | 解像度: 1.6→1.69 Å / 冗長度: 4 % / Rmerge(I) obs: 1.01 / Mean I/σ(I) obs: 2 / Num. unique all: 25196 / Rsym value: 1.01 / % possible all: 100 |
-
解析
| ソフトウェア |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 精密化 | 構造決定の手法: 分子置換開始モデル: PDB entry 2SHP 解像度: 1.6→34.12 Å / Cor.coef. Fo:Fc: 0.967 / Cor.coef. Fo:Fc free: 0.95 / SU B: 3.422 / SU ML: 0.058 / TLS residual ADP flag: LIKELY RESIDUAL / 交差検証法: THROUGHOUT / σ(F): 0 / ESU R: 0.079 / ESU R Free: 0.085 / 立体化学のターゲット値: MAXIMUM LIKELIHOOD / 詳細: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 溶媒の処理 | イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.2 Å / 溶媒モデル: MASK | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 原子変位パラメータ | Biso mean: 16.903 Å2
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 精密化ステップ | サイクル: LAST / 解像度: 1.6→34.12 Å
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 拘束条件 |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS精密化 シェル | 解像度: 1.6→1.642 Å / Total num. of bins used: 20
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 精密化 TLS | 手法: refined / Origin x: 17.0831 Å / Origin y: 10.0483 Å / Origin z: 63.979 Å
|
ムービー
コントローラー
万見について




Homo sapiens (ヒト)
X線回折
引用

























PDBj





































